cbdMD FY26 Q3 operating loss widens to $1.13 million; net sales rise 20% to $5.6 million

Reuters2026/08/13 20:18

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

cbdMD posted fiscal Q3 net sales of $5.6 million, up 20% year over year, driven by a 61% wholesale jump.
Operating loss widened to $1.13 million; net loss attributable to common shareholders was $1.2 million, or $0.11 per share.
Gross margin fell 6.8 percentage points to 54.7% on mix shift to wholesale, added warehousing/repacking, higher inventory reserves tied to regulatory changes.
Oasis distributor depletions rose 25% in the quarter; Bluebird Botanicals added more than $0.5 million in its first full-quarter contribution.
Management cited July cost cuts targeting $100,000-$150,000 in monthly savings, alongside one-time M&A diligence and legal costs.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. cbdMD Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: CL25528) on August 13, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

cbdMD FY26 Q3 operating loss widens to $1.13 million; net sales rise 20% to $5.6 million

You may also like

Crypto prices